This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)
C3_SECONDARY_NAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
9433 |
4. Check minimum number of eventsNone |
9433 |
5. Include endpointsNone |
9433 |
6. Filter based on genotype QC (FinnGen only) |
9433 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9433 | 4278 | 5155 |
| Unadjusted period prevalence (%) | 1.90 | 1.46 | 2.27 |
| Median age at first event (years) | 69.68 | 67.39 | 71.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 324
- Matched controls
- 3238
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
444.7
239.4
214
14
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
208.6
177
*
130
Kela drug reimbursment
Malignant tumour
+∞
203.2
173
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
165.1
144
*
A03FA01
ATC
metoclopramide; systemic, rectal
35.2
156.5
228
204
JN4BD
NOMESCO Finland
Extensive body CT
56.9
152.8
182
71
Z51.5
ICD-10 Finland
Palliative care
98.5
151.3
161
32
N02AA05
ATC
oxycodone; systemic
31.9
146.6
217
193
A04AA02
ATC
granisetron; systemic, transdermal
1889.9
133.0
120
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
130.2
116
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
105.0
95
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
103.9
94
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
96.8
88
*
XX3DW
NOMESCO Finland
Time consuming IT work
31.2
91.0
124
63
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
86.4
79
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
11.2
84.3
215
483
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
72.7
67
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
65.9
61
*
M05BX04
ATC
denosumab; parenteral
27.2
64.3
90
45
C61
ICD-10 Finland
Malignant neoplasm of prostate
744.5
64.1
61
*
116
Kela drug reimbursment
Prostate cancer
+∞
61.4
57
*
JN4CD
NOMESCO Finland
Very extensive body CT
56.4
60.7
71
16
L01BC06
ATC
capecitabine; oral
+∞
59.2
55
*
115
Kela drug reimbursment
Breast cancer
+∞
57.0
53
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
26.9
55.1
77
37
A04AA01
ATC
ondansetron; systemic, rectal
32.7
54.6
72
28
NK6AN
NOMESCO Finland
Total body bone isotope imaging
191.5
48.3
49
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
48.1
45
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
73.5
44.6
50
8
L03AA13
ATC
pegfilgrastim; parenteral
+∞
43.7
41
*
L02BG04
ATC
letrozole; oral
476.7
43.2
42
*
L02AE02
ATC
leuprorelin; implant, parenteral
123.4
40.8
43
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
155.8
39.7
41
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
38.3
36
*
A04AD12
ATC
aprepitant; systemic
+∞
37.2
35
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.7
37.0
222
1029
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
36.1
34
*
WW500
NOMESCO Finland
Blood transfusion
27.2
35.7
49
21
WZC30
NOMESCO Finland
Teaching
7.3
35.2
93
168
L02BB03
ATC
bicalutamide; oral
+∞
35.0
33
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
35.0
33
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
33.9
32
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
369.9
33.5
33
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
32.9
31
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
31.8
30
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
31.8
30
*
PJA12
NOMESCO Finland
Sentinel node biopsy
344.2
31.4
31
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
344.2
31.4
31
*
JN4AD
NOMESCO Finland
Body CT examination
14.9
31.2
53
42
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
30.7
29
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
30.7
29
*
L02BA01
ATC
tamoxifen; oral
331.5
30.3
30
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
29.6
28
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
29.6
28
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
318.9
29.3
29
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.5
29.1
83
163
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
28.6
27
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
306.4
28.2
28
*
Y77
ICPC
Malignant neoplasm prostate
306.4
28.2
28
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
27.5
26
*
L02BB04
ATC
enzalutamide; oral
+∞
27.5
26
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
19.4
27.0
41
24
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
26.4
25
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
26.4
25
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
26.4
25
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
24.3
23
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.8
23.5
72
152
WX302
NOMESCO Finland
Thoracal epidural anesthesy
19.4
23.2
35
20
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
23.2
22
*
L02BA03
ATC
fulvestrant; parenteral
+∞
23.2
22
*
L01CA04
ATC
vinorelbine; systemic
+∞
23.2
22
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
23.2
22
*
A02BC02
ATC
pantoprazole; systemic
3.6
23.1
252
1595
X76
ICPC
Malignant neoplasm breast female
+∞
22.1
21
*
192
Kela drug reimbursment
Fulvestrant
+∞
22.1
21
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
22.1
21
*
B01AB10
ATC
tinzaparin; parenteral
8.4
22.0
50
69
ZX120
NOMESCO Finland
Intravenous
6.9
21.8
57
97
HA1AA
NOMESCO Finland
X-ray mammography
14.2
21.8
37
29
A06AH03
ATC
naloxegol; oral
46.9
21.7
26
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
21.4
147
649
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.0
21.2
62
123
L03AA02
ATC
filgrastim; parenteral
+∞
21.1
20
*
A79
ICPC
Malignancy NOS
117.6
20.8
22
*
L02AE03
ATC
goserelin; implant
223.7
20.8
21
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
21.9
20.8
30
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.6
20.3
29
14
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
20.0
19
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
20.0
19
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
15.3
19.5
32
23
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.6
19.5
47
71
B01AB05
ATC
enoxaparin; parenteral
3.3
19.4
130
553
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
18.9
18
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
17.9
17
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
17.9
17
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
17.9
17
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
39.1
17.8
22
6
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
67.0
16.9
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
16.9
109
445
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.8
16
*
L02BX03
ATC
abiraterone; oral
+∞
16.8
16
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
16.5
16.5
26
17
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
50.2
16.2
19
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
15.7
15
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
L02BX02
ATC
degarelix; parenteral
+∞
15.7
15
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
15.4
66
194
J01MA12
ATC
levofloxacin; systemic
3.2
15.2
96
381
HAB40
NOMESCO Finland
Wedge excision of mammary gland
33.5
15.0
19
6
R50.9
ICD-10 Finland
Fever, unspecified
3.9
14.9
67
205
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
14.7
14
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.5
14.6
55
142
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
13.8
83
317
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.9
13.7
46
106
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
13.6
13
*
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
+∞
13.6
13
*
L02BG06
ATC
exemestane; oral
+∞
13.6
13
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
13.6
13
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
13.6
13
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
13.6
13
*
N02BE01
ATC
paracetamol; systemic, rectal
3.4
13.3
290
2315
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.6
13.3
48
119
ZX112
NOMESCO Finland
Subcutaneous
21.1
12.6
18
9
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
12.6
12
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.6
12
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
12.6
12
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
12.6
12
*
R83
ICPC
Respiratory infection other
0.0
12.5
*
297
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
12.5
43
101
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
134.9
12.5
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
134.9
12.5
13
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.1
12.2
74
280
SPAT1254
SPAT
Administration of medicine
3.2
11.9
70
260
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
17.2
11.8
18
11
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.7
11.7
54
167
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
11.5
11
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
11.5
11
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
11.5
11
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
11.5
11
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
11.5
11
*
L01CB01
ATC
etoposide; systemic
+∞
11.5
11
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
11.5
11
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
11.5
11
*
1501
Kela drug reimbursment
Palbociclib
+∞
11.5
11
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
124.2
11.5
12
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
11.4
80
331
N02AX02
ATC
tramadol; systemic, rectal
2.3
11.2
158
956
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.0
11.1
45
125
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
44.9
11.0
13
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
62.1
10.7
12
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
10.5
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
10.5
10
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
10.5
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
10.5
10
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
10.5
10
*
L01XE33
ATC
[U] palbociclib; oral
+∞
10.5
10
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
10.5
10
*
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
10.5
10
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
10.5
10.2
19
19
J94.8
ICD-10 Finland
Other specified pleural conditions
15.2
10.1
16
11
NF3AA
NOMESCO Finland
Femur X-ray examination
8.8
9.7
20
24
TGD00
NOMESCO Finland
Needle biopsy of lung
56.7
9.7
11
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
18.2
9.5
14
8
WF099
NOMESCO Finland
Other radiotherapy
102.9
9.5
10
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
9.4
9
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
9.4
9
*
L01AX03
ATC
temozolomide; systemic
+∞
9.4
9
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
9.4
9
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
+∞
9.4
9
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
9.4
9
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
9.4
9
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
9.4
9
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
37.8
9.1
11
*
A06AD11
ATC
lactulose; oral
2.6
9.0
71
315
N03AX14
ATC
levetiracetam; systemic
8.3
9.0
19
24
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
8.8
104
565
N03AX16
ATC
pregabalin; oral
2.3
8.7
92
474
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
8.5
81
393
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.0
8.4
*
204
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
8.4
8
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
8.4
8
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
8.4
8
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
+∞
8.4
8
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
8.4
8
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
8.4
8
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.4
8
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
8.4
8
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
8.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.4
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.4
8
*
394
Kela drug reimbursment
Palbociclib
+∞
8.4
8
*
180
Kela drug reimbursment
Interferon alfa
+∞
8.4
8
*
L17
ICPC
Foot/toe symptom/complaint
0.3
8.2
17
529
SPAT1109
SPAT
Analgesia with portable analgesic pump
34.3
8.1
10
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
10.4
8.1
15
15
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.2
8.1
30
77
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
22.7
8.1
11
5
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.0
8.1
149
970
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.9
8.0
25
54
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.1
8.0
*
252
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.7
8.0
22
41
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
25.7
7.6
10
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.3
7.5
38
127
N02AA01
ATC
morphine; systemic, rectal
13.8
7.4
12
9
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
6.0
7.3
19
33
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
7.3
7
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
GDC00
NOMESCO Finland
Lobectomy of lung
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
1CD02
NOMESCO Finland
NA
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
L01XE23
ATC
[U] dabrafenib; oral
+∞
7.3
7
*
R84
ICPC
Malignant neoplasm bronchus/lung
+∞
7.3
7
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
+∞
7.3
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
7.3
7
*
GA5AA
NOMESCO Finland
Rib X-ray examination
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
7.3
7
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
+∞
7.3
7
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
7.3
7
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
7.3
7
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
20.6
7.2
10
5
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.9
7.2
22
47
H02AB06
ATC
prednisolone; systemic
1.9
7.0
160
1105
WW200
SPAT
NA
0.0
6.9
*
169
SPAT1111
SPAT
Planning of analgesia
12.6
6.6
11
9
A41.9
ICD-10 Finland
Sepsis, unspecified
4.7
6.6
21
47
C03CA01
ATC
furosemide; systemic
1.9
6.6
125
805
JFF23
NOMESCO Finland
Transversostomy
71.2
6.4
7
*
L02BG03
ATC
anastrozole; oral
71.2
6.4
7
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.5
6.3
12
13
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
6.3
6
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
6.3
6
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
6.3
6
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
6.3
6
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
197
Kela drug reimbursment
Sunitinib
+∞
6.3
6
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
6.3
6
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
6.3
6
*
L01XE25
ATC
[U] trametinib; oral
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
D75
ICPC
Malignant neoplasm colon/rectum
+∞
6.3
6
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
6.3
6
*
159
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
6.3
6
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
6.3
6
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
6.3
6
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
6.3
6
*
L01BC53
ATC
tegafur, combinations; systemic
+∞
6.3
6
*
A98
ICPC
Health maint/preventive medicine
0.5
6.2
229
2674
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.8
6.1
10
8
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
12.8
6.1
10
8
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
12.8
6.1
10
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
6.1
70
371
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
6199
77472
0.42
323.01
3.6
4.8
1.4
1.4
mmol/l
8.82
5339
70764
2608
12349
2.54
321.19
2.3
1.9
29.6
30.0
s
2.65
2547
11953
506
771
6.88
317.54
1.1
1.1
—
—
—
0
0
6303
78122
0.42
316.11
3.6
4.9
4.6
4.5
mmol/l
6.70
5417
71865
686
1419
5.13
312.73
1.4
1.5
—
—
—
0
0
1459
5168
3.16
312.00
1.6
1.6
—
—
—
0
0
3807
21577
2.28
309.45
3.6
3.0
0.7
0.4
e6/l
4.86
3135
16075
7856
40839
6.52
307.65
28.7
6.3
4.1
4.3
e9/l
13.14
7400
34902
1712
6246
3.13
307.65
7.9
3.1
1.2
1.2
mmol/l
1.59
1660
5262
5888
24095
4.84
307.65
13.4
2.1
2.3
2.4
mmol/l
4.45
5616
20016
5881
38611
2.39
307.65
6.9
5.5
0.2
0.2
e9/l
61.79
5165
33460
1867
5784
3.78
307.65
2.4
2.0
0.2
0.2
g/l
9.44
1779
5242
3453
16783
2.67
307.65
3.2
2.2
—
—
—
0
0
4545
24265
2.68
307.65
4.5
2.3
54.7
60.0
u/l
6.63
4336
22160
8062
37469
8.92
307.65
23.6
3.8
10.4
12.1
umol/l
28.61
7965
35043
5623
34470
2.56
307.65
6.6
5.6
2.4
3.0
%
68.15
5393
31699
8412
58709
5.00
307.65
27.2
5.5
111.0
76.0
u/l
149.61
8283
54276
4890
27876
2.57
307.65
3.7
3.2
—
0.8
—
0
6
5502
33457
2.55
307.65
6.7
5.7
0.6
0.7
%
28.97
5280
30808
4326
4316
17.67
307.65
7.8
1.5
79.3
9.9
ug/l
8.48
3953
3263
5482
35046
2.35
307.65
6.6
5.6
61.6
57.8
%
77.53
5260
32340
5686
34644
2.61
307.65
6.8
5.9
9.0
8.8
%
3.90
5461
32004
1656
6147
3.05
307.65
5.6
1.8
402.3
365.3
nmol/l
8.42
1603
5550
6796
35441
4.28
307.65
9.8
5.4
1.2
1.2
mmol/l
0.28
6596
31377
5756
35391
2.61
307.65
6.8
5.7
22.1
27.2
%
186.80
5505
32485
6982
46503
2.93
307.65
6.9
4.5
6.9
6.9
mmol/l
0.01
6797
43394
7369
39184
5.02
307.65
12.5
5.9
1.2
1.2
mmol/l
1.11
5999
32892
6695
32434
4.67
307.65
9.9
3.9
32.1
35.5
g/l
307.65
6461
29630
5756
37388
2.38
307.65
6.7
5.4
0.0
0.0
e9/l
38.25
5017
31919
5855
38133
2.41
307.65
6.8
5.4
1.6
1.8
e9/l
15.22
5163
33124
1347
2128
7.22
307.65
6.0
1.5
102.7
27.9
u/ml
13.61
1325
2022
3628
18212
2.61
307.65
6.2
3.6
88.7
86.2
%
8.14
3574
17736
1301
3094
4.72
307.65
2.0
1.9
3.1
1.8
ug/l
0.63
1216
2696
1239
945
14.94
307.65
5.4
1.9
1232.1
1036.8
u/ml
0.10
1154
853
710
375
20.39
307.65
5.3
1.7
14.6
4.7
nmol/l
4.09
705
360
796
65
133.65
307.65
8.6
1.1
112.4
20.2
u/ml
15.13
789
60
4017
11476
5.35
307.65
5.7
2.5
0.8
0.8
mmol/l
42.27
3901
10491
5741
33036
2.88
307.65
5.7
3.7
—
—
—
0
0
6465
79917
0.39
307.65
3.9
5.5
2.7
2.6
mmol/l
7.03
5500
73217
4278
23430
2.51
307.65
3.7
3.1
116.5
103.3
e6/l
0.17
3564
17838
3703
13740
3.79
307.65
9.1
2.2
2.5
2.4
mmol/l
68.36
3520
11756
6067
33192
3.32
307.65
7.8
10.4
1.2
1.3
inr
44.88
1896
9141
476
624
7.98
307.65
2.8
1.9
650.4
454.8
u/ml
0.16
465
607
851
1025
9.03
307.65
1.3
1.3
—
—
—
0
0
1533
1555
11.58
307.65
6.0
1.9
2377.0
83.3
u/ml
2.90
1379
1264
2773
7860
4.58
307.65
6.0
2.7
284.3
241.0
u/l
16.40
2705
7290
7134
50584
2.68
307.65
5.3
4.4
650.6
1559.7
e6/l
1.45
129
765
2968
12820
2.92
307.65
2.0
1.8
—
—
—
0
0
1088
446
27.44
307.65
2.5
1.3
30.1
20.1
ug/l
3.21
1071
431
1018
101
112.86
307.65
9.8
1.0
103.0
23.4
u/ml
10.41
1002
90
4471
27244
2.22
302.21
4.4
3.5
124.9
111.9
e6/l
0.40
3655
19248
534
929
6.03
293.82
2.1
2.9
2.0
1.2
%
4.56
418
704
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
921
2520
3.94
293.27
2.5
3.2
0.4
0.3
u/ml
0.41
548
1509
2157
9718
2.58
291.40
7.4
6.7
103.7
104.3
mmol/l
7.37
2123
9485
3040
16300
2.28
275.73
2.9
2.5
6.3
4.7
e6/l
6.10
2759
14089
1318
4744
3.07
271.99
2.4
2.1
4.0
14.5
nmol/l
307.42
1087
4113
1992
8899
2.57
271.90
1.9
1.7
—
—
—
0
0
1986
8891
2.56
269.66
1.9
1.7
—
—
—
0
0
205
104
20.13
267.03
1.1
1.1
—
—
—
0
0
1266
4521
3.08
264.49
1.7
1.5
—
—
—
0
0
344
420
8.46
261.81
1.2
1.3
—
—
—
0
0
6060
74924
0.47
252.28
5.6
6.5
41.4
40.6
mmol/mol
5.69
5345
68813
485
907
5.58
246.74
1.3
1.5
37.1
29.7
g/l
27.55
455
801
1756
7788
2.54
240.58
4.2
2.2
16.6
8.1
umol/l
13.87
1578
6706
641
1565
4.32
237.14
1.4
1.4
—
—
—
0
0
3790
23274
2.05
233.57
6.9
2.6
44.5
35.1
u/l
2.79
3666
21834
6115
74908
0.48
233.13
3.4
4.3
1.4
1.3
mmol/l
16.99
5246
67839
2046
9907
2.36
229.98
4.9
5.6
1.0
1.0
mmol/l
2.02
1935
9114
520
1102
4.94
229.37
1.4
1.5
—
—
—
0
0
618
1507
4.32
228.86
1.4
1.4
—
—
—
0
0
862
22276
0.33
226.71
1.5
1.6
1.6
1.3
mmol/l
8.26
713
18351
1158
4362
2.89
217.70
4.7
7.5
24.8
24.8
mmol/l
0.12
1147
4317
1585
7107
2.48
209.71
6.3
7.2
8.7
11.0
mmol/l
28.41
1509
6708
1457
6380
2.52
202.31
3.6
2.2
42.5
46.1
u/l
0.18
1312
5380
1675
7896
2.36
197.23
5.3
3.3
—
—
—
0
0
710
2136
3.51
194.43
1.6
1.7
—
—
—
0
0
1354
5865
2.53
191.70
3.1
3.7
0.2
0.1
%
6.45
797
1215
396
817
5.02
179.84
1.4
1.5
2079.9
2476.1
e6/l
0.34
297
597
606
1739
3.66
177.97
3.8
4.3
2.8
2.5
mmol/l
1.42
435
1165
606
1741
3.65
177.66
3.8
4.3
5.0
5.0
kpa
0.70
596
1697
203
210
9.86
175.33
2.2
3.0
—
—
—
0
0
4685
33105
1.82
172.09
20.8
8.7
0.0
0.0
e9/l
4.72
3893
27062
2208
12264
2.04
169.32
3.5
2.8
2.6
2.3
e6/l
0.80
1400
6651
499
1301
3.99
168.09
4.0
3.3
60.6
58.4
%
2.50
499
1301
1258
5600
2.44
166.43
3.0
3.5
1.0
0.6
%
6.63
594
984
358
734
5.03
163.67
1.3
1.5
33908.1
63109.9
e6/l
1.37
229
430
322
610
5.43
160.99
1.2
1.3
484.5
314.8
u/l
1.83
310
577
315
596
5.43
157.69
1.3
1.4
6.0
6.7
mmol/l
3.12
297
543
1411
6752
2.28
157.58
5.2
6.9
1.5
1.4
mmol/l
1.17
1338
6509
741
2593
3.02
157.29
2.2
2.9
—
—
—
0
0
397
920
4.46
156.30
1.4
1.4
—
—
—
0
0
1971
10780
2.05
156.13
2.1
2.7
21.0
22.6
%
4.22
1766
9009
650
2143
3.18
152.79
1.2
1.2
—
—
—
0
0
1743
9204
2.10
151.34
5.6
7.2
1.4
1.3
mmol/l
0.59
1361
7155
2051
11546
1.99
148.97
2.1
2.6
2.2
2.3
g/l
18.59
1940
10595
1735
9239
2.08
146.85
5.6
7.2
5.0
5.1
kpa
0.28
1650
8807
1734
9232
2.08
146.84
5.6
7.2
13.2
11.6
kpa
22.99
1645
8789
452
1225
3.82
143.90
1.7
1.3
15.7
9.9
u/l
9.69
376
976
331
709
4.80
143.57
1.4
1.5
—
—
—
0
0
129
94
13.90
139.80
8.8
1.5
52.2
53.0
u/l
0.02
53
36
2138
12557
1.91
135.30
2.2
2.6
11.1
12.9
umol/l
22.31
2031
11517
254
460
5.65
133.27
1.4
1.7
—
—
—
0
0
6790
77590
0.55
130.88
4.5
5.0
6.2
6.1
mmol/l
6.84
5949
70167
431
1226
3.64
127.68
1.4
1.4
—
—
—
0
0
792
3247
2.57
123.32
2.2
1.8
—
—
—
0
0
364
953
3.93
121.54
1.4
1.4
—
—
—
0
0
171
226
7.69
121.48
1.3
1.4
63.1
64.4
%
0.16
145
185
384
1071
3.69
117.04
1.4
1.3
—
—
—
0
0
4391
32713
1.64
115.51
4.2
3.9
34.5
83.2
ng/l
4.43
3735
23864
8551
76550
2.25
115.10
38.3
13.6
35.9
24.2
mg/l
157.69
8225
60228
381
1072
3.66
114.61
2.3
5.5
6661.5
942.1
iu/ml
0.47
37
158
351
937
3.85
113.98
1.4
1.3
—
—
—
0
0
354
951
3.83
113.92
1.5
1.4
267.0
75.7
pmol/l
4.09
346
924
501
1683
3.09
113.49
2.4
2.5
15.1
16.5
%
7.53
221
905
1393
7489
2.01
112.16
6.2
8.0
114.3
122.7
g/l
44.52
1346
7209
1510
8352
1.96
112.04
6.0
7.5
95.5
95.2
%
0.76
1446
8035
1016
4874
2.22
110.41
7.0
9.2
94.2
93.5
%
3.00
1011
4858
1414
7708
1.98
109.21
3.6
3.8
2.1
1.9
mmol/l
1.03
1126
6296
116
9
130.48
108.26
1.0
1.0
—
—
—
0
0
718
2990
2.52
107.77
2.0
1.7
—
—
—
0
0
1411
7720
1.97
107.71
3.6
3.8
5.7
5.8
kpa
5.81
1365
7501
230
477
4.92
103.58
1.2
1.3
11.1
11.9
u/l
0.51
217
433
247
544
4.64
103.45
1.5
1.4
—
—
—
0
0
398
1247
3.29
101.20
1.8
1.9
1.8
1.7
mmol/l
1.09
390
1223
144
193
7.56
101.06
1.3
1.4
3.2
2.3
%
0.54
125
163
986
4858
2.15
99.71
6.9
9.2
0.7
0.7
%
3.32
977
4826
192
356
5.48
98.17
1.5
1.4
—
—
—
0
0
191
353
5.50
98.00
1.5
1.4
—
—
—
0
0
248
574
4.41
97.59
1.4
1.3
—
—
—
0
0
248
574
4.41
97.59
1.4
1.3
—
—
—
0
0
248
574
4.41
97.59
1.4
1.3
—
—
—
0
0
970
4799
2.14
96.92
1.9
1.6
—
—
—
0
0
498
1822
2.83
96.55
1.8
2.4
3.9
3.6
g/l
2.72
484
1720
452
1572
2.97
96.14
2.0
2.6
39.3
33.1
umol/l
3.62
341
1341
1248
6822
1.96
94.62
3.9
1.6
64.5
66.8
g/l
18.57
1162
6110
205
421
4.95
93.39
1.4
1.3
—
—
—
0
0
974
4901
2.10
92.93
6.8
9.0
1.4
1.4
%
0.24
965
4868
236
547
4.40
92.69
1.7
1.3
32.6
32.6
u/l
0.01
227
396
2094
13530
1.70
91.08
3.2
2.6
2.7
1.1
e6/l
0.69
1281
7851
148
236
6.35
88.45
8.8
1.2
148.2
197.3
u/ml
0.23
53
57
867
4253
2.14
88.20
3.4
2.6
0.4
0.3
e6/l
1.16
855
4157
247
646
3.90
82.49
2.0
2.8
61.9
61.0
%
0.22
144
427
78
0
+∞
81.35
1.1
0.0
—
—
—
0
0
2909
20894
1.57
80.76
4.8
4.1
0.0
0.0
estimate
0.10
1181
6342
430
1600
2.77
80.58
1.3
1.3
—
—
—
0
0
430
1600
2.77
80.58
1.3
1.3
—
—
—
0
0
1520
9272
1.76
80.12
2.5
2.1
2.0
1.8
%
8.72
1385
8081
250
677
3.77
79.44
1.4
1.4
—
—
—
0
0
2808
20105
1.56
78.59
1.9
2.3
3.6
2.9
mg/l
25.45
2458
17060
122
180
6.85
78.54
1.3
1.4
17.6
22.3
%
1.02
112
160
237
625
3.86
78.23
1.4
1.4
—
—
—
0
0
799
4057
2.06
73.71
6.9
9.2
24.6
24.5
mmol/l
0.69
763
3711
201
494
4.14
73.12
1.3
1.4
11.0
13.2
u/l
6.44
193
474
125
210
6.02
70.94
1.3
2.6
4179.1
556.2
e6/l
0.55
85
153
94
120
7.90
68.79
1.6
2.1
—
—
—
0
0
180
430
4.25
68.01
1.7
1.9
—
—
—
0
0
626
2992
2.17
67.52
3.9
4.3
1.5
1.4
mmol/l
0.87
611
2934
1102
6418
1.81
67.10
3.3
3.2
4.5
4.5
kpa
0.04
1052
6209
113
182
6.27
66.91
1.3
2.4
16950.8
20786.5
e6/l
0.10
66
95
260
816
3.25
65.83
1.4
2.6
811.8
11110.0
u/ml
0.47
11
51
146
308
4.80
64.47
1.5
1.4
—
—
—
0
0
146
308
4.80
64.47
1.5
1.4
—
—
—
0
0
146
308
4.80
64.47
1.5
1.4
—
—
—
0
0
146
309
4.78
64.22
1.5
1.4
—
—
—
0
0
948
5348
1.86
63.84
3.3
3.6
5.1
5.1
kpa
1.18
872
4924
673
12459
0.50
63.36
1.2
1.3
22.0
14.5
u/ml
0.57
260
4574
910
5089
1.87
62.95
3.3
3.5
2.1
1.8
mmol/l
1.38
671
3744
439
1870
2.41
62.13
1.8
2.1
89.9
89.5
%
0.11
431
1735
711
3685
2.01
61.62
3.5
4.2
24.1
24.2
mmol/l
0.05
663
3256
941
5355
1.84
61.52
6.2
7.2
24.7
24.6
mmol/l
0.41
887
4977
75
84
8.99
60.99
1.2
1.2
—
—
—
0
0
744
13203
0.53
60.96
1.2
1.3
47.0
38.1
iu/ml
0.69
218
4099
120
227
5.34
60.08
1.6
1.4
—
—
—
0
0
119
225
5.34
59.62
1.6
1.4
—
—
—
0
0
119
225
5.34
59.62
1.6
1.4
—
—
—
0
0
2187
29501
0.66
58.71
3.8
4.1
12.7
9.0
mg/mmol
2.53
1398
18797
395
1653
2.45
58.09
1.7
1.3
31.7
33.4
iu/l
0.45
334
1429
2059
27929
0.66
56.10
3.1
3.3
711.6
297.2
mg/l
2.64
1337
17832
404
1738
2.38
55.88
1.9
2.4
232.5
193.4
%
11.24
389
1638
414
1805
2.35
55.55
2.6
3.1
8.0
7.9
kpa
0.43
384
1674
3378
26658
1.42
52.79
3.0
3.1
1387.7
1489.3
ng/l
0.56
3062
23032
71
90
7.94
52.29
1.3
1.4
14.0
9.3
%
0.72
50
44
2138
28462
0.68
51.71
2.9
3.2
7.3
7.5
mmol/l
1.14
1690
23779
6483
71526
0.70
51.57
5.8
4.7
3.0
2.1
mu/l
1.01
5786
64628
57
57
10.05
50.39
2.5
2.2
1611.7
4614.7
u/l
0.48
47
49
1105
6998
1.66
48.85
2.8
2.2
72.8
69.0
e9/l
2.16
851
5346
94
172
5.51
48.85
1.2
1.3
584.2
59.9
ug/l
3.31
72
75
264
995
2.70
48.19
5.3
6.5
11.5
12.0
mg/l
1.17
237
902
91
167
5.49
47.15
1.1
1.2
—
—
—
0
0
116
263
4.45
46.96
1.8
2.0
—
—
—
0
0
1720
12175
1.50
46.70
16.2
29.0
1.3
1.5
inr
6.03
290
1663
723
4127
1.81
46.31
7.8
10.1
—
—
—
0
0
507
2583
2.02
45.85
4.1
4.6
3.9
3.9
mmol/l
0.36
478
2439
456
2238
2.09
45.65
1.4
1.4
214.0
284.1
ug/g
10.92
311
1324
31
12
25.91
44.47
6.2
1.3
0.0
—
estimate
—
9
0
116
283
4.14
42.73
1.6
2.0
17.6
16.5
%
0.14
18
121
44
39
11.33
42.19
2.6
1.0
19.0
1.5
ug/l
0.96
31
17
57
73
7.85
41.63
1.2
1.3
19.7
22.6
%
0.22
46
55
186
4817
0.37
40.96
1.5
1.9
—
—
—
0
0
723
4299
1.74
40.10
3.7
3.3
25.2
25.2
mmol/l
0.01
707
4171
3566
29324
1.35
39.93
4.9
4.0
—
—
—
0
0
429
2179
2.01
39.08
2.8
3.0
24.9
24.7
mmol/l
0.16
360
1918
81
159
5.13
39.00
1.3
1.4
21.5
26.1
%
0.65
71
131
8597
81428
1.63
38.63
37.9
16.6
138.4
139.8
mmol/l
307.65
8438
79251
1052
15364
0.65
38.02
1.2
1.2
1.4
1.8
u/ml
0.99
291
4020
97
226
4.33
37.99
2.5
2.5
41.4
42.5
%
0.10
16
79
8600
81619
1.61
36.42
38.1
16.7
4.0
4.0
mmol/l
0.16
8432
79319
4500
38609
1.32
36.31
4.6
3.7
0.0
0.0
estimate
2.04
1309
6343
167
578
2.92
35.85
1.1
1.1
—
—
—
0
0
4436
38126
1.31
34.72
5.7
4.9
0.0
0.0
estimate
0.80
1319
6567
661
4015
1.69
33.79
2.8
2.8
1.2
1.2
%
0.39
656
3993
45
57
7.93
33.18
1.3
2.5
51.6
64.7
%
0.99
28
36
817
5270
1.60
32.92
3.3
3.3
117.4
130.5
g/l
48.87
807
5130
220
917
2.43
32.69
1.5
1.3
—
—
—
0
0
219
911
2.44
32.68
1.5
1.3
—
—
—
0
0
645
3929
1.69
32.60
2.9
2.8
0.7
0.7
%
3.20
635
3752
526
3029
1.78
32.50
2.0
2.4
241.1
692.8
ug/l
4.67
500
2851
656
4021
1.68
32.38
5.0
3.0
4.3
4.4
pmol/l
3.28
601
3522
222
943
2.39
31.65
1.5
1.3
—
—
—
0
0
325
1615
2.05
31.45
1.4
1.3
—
—
—
0
0
214
900
2.41
31.19
1.5
1.3
—
—
—
0
0
214
901
2.41
31.12
1.5
1.3
—
—
—
0
0
214
903
2.40
30.97
1.5
1.3
—
—
—
0
0
2117
16615
1.35
30.43
4.1
4.0
182.9
592.7
ng/l
10.05
1736
13731
4396
38137
1.29
30.42
4.5
3.7
0.0
0.0
estimate
0.50
1317
6463
106
311
3.44
30.06
1.7
2.1
494.8
720.0
e6/l
1.73
25
141
56
2303
0.24
29.60
1.7
1.7
5.9
3.7
mg/l
0.77
47
1625
87
227
3.86
29.34
1.0
1.4
—
—
—
0
0
244
1125
2.20
28.71
1.4
1.3
—
—
—
0
0
2089
16533
1.34
28.04
1.7
1.7
2.5
1.2
mg/l
20.27
1766
12747
72
170
4.26
27.81
1.1
1.7
13.0
13.9
g/l
0.35
57
128
174
702
2.51
27.79
3.7
1.7
16.1
2181.9
u/l
4.04
71
265
343
1821
1.92
27.49
3.3
2.9
1.4
1.7
mg/l
12.32
321
1625
176
719
2.48
27.38
2.7
2.8
—
—
—
0
0
129
453
2.87
27.08
1.6
1.3
0.2
0.3
nmol/l
2.16
75
346
128
449
2.88
26.92
1.9
1.5
6.4
6.9
u/l
0.11
76
196
176
750
2.37
24.99
1.5
1.2
140.6
56.9
u/l
2.21
127
476
49
92
5.35
24.88
1.2
1.2
0.8
1.7
mmol/l
0.52
40
53
528
3303
1.63
23.98
3.7
3.9
25.1
24.9
mmol/l
0.76
481
3030
127
476
2.69
23.63
1.3
1.3
—
—
—
0
0
30
35
8.59
23.62
7.8
1.2
1510.9
1.5
pmol/l
—
19
9
260
1334
1.98
23.08
1.5
1.8
333.5
307.1
mu/l
0.82
254
1219
124
468
2.67
22.77
1.3
1.3
—
—
—
0
0
301
1636
1.87
22.49
1.4
1.7
2.9
4.4
iu/l
4.40
74
557
59
145
4.09
21.69
1.1
1.5
23.8
65.9
g/l
0.52
48
112
71
202
3.53
21.22
1.2
2.1
90.0
54615.0
u/ml
—
5
32
5395
58692
0.81
21.00
5.4
3.8
15.1
14.9
pmol/l
6.41
4876
52643
334
1916
1.77
20.93
2.4
2.2
120.3
131.1
g/l
10.72
263
1384
778
10845
0.69
20.78
3.5
5.0
31.1
32.7
%
3.83
521
7263
96
335
2.88
20.49
1.4
1.2
—
—
—
0
0
96
335
2.88
20.49
1.4
1.2
—
—
—
0
0
5227
47456
1.23
20.41
4.1
3.0
103.6
48.8
u/l
61.93
4872
43349
3138
36025
0.81
20.27
1.8
2.0
86.7
94.7
pmol/l
19.59
1955
18557
6647
61942
1.25
20.14
46.7
16.3
15.1
13.7
%
307.65
6577
60414
32
51
6.29
19.24
1.3
2.4
23.1
12.1
%
0.72
15
29
878
6439
1.40
18.46
5.3
2.5
62.5
62.5
ml/min/173m2
0.01
382
2530
17
0
+∞
17.71
1.1
0.0
—
—
—
0
0
97
372
2.62
17.37
1.2
1.1
116.5
85.4
u/l
1.08
88
285
96
370
2.61
17.03
1.2
1.1
61.0
22.6
u/l
1.89
83
275
151
714
2.13
16.85
1.3
1.4
272.3
277.5
mosm/kgh2o
2.28
131
543
524
3549
1.50
16.79
4.7
4.9
1.6
1.6
%
0.24
491
3341
250
4258
0.58
16.50
1.3
1.3
367.9
238.0
u/ml
0.61
226
3918
579
8177
0.69
16.40
2.0
2.1
243.0
144.5
ug/g
3.27
469
6344
516
3504
1.50
16.33
4.7
5.0
0.9
0.9
%
0.06
484
3297
8514
82334
1.35
16.03
29.7
9.5
26.7
25.8
u/l
3.60
8360
78691
3050
26721
1.21
15.57
2.5
2.2
177.6
229.5
u/l
2.66
2884
24900
50
139
3.61
15.56
1.2
1.2
1.8
1.4
mmol/l
2.22
41
74
89
348
2.57
15.38
2.0
1.4
4.1
4.0
mg/l
0.04
83
330
547
3808
1.46
15.29
1.4
1.5
2.0
1.5
g/l
15.10
458
3236
30
57
5.28
15.10
1.9
1.2
81.6
104.2
ng/l
—
7
17
1026
7953
1.33
15.02
2.8
3.1
162.6
221.5
ng/l
4.56
944
7322
19
6
31.72
14.78
1.1
1.0
—
—
—
0
0
36
84
4.30
14.25
1.3
1.3
39.8
421.5
u/l
0.47
30
55
46
132
3.50
13.70
1.1
1.1
—
—
—
0
0
261
1588
1.66
13.33
1.3
1.6
—
—
—
0
0
32
72
4.46
13.27
1.1
1.1
26.3
16.2
u/l
1.22
26
45
175
951
1.86
13.25
1.2
1.1
1.6
1.5
g/l
2.74
161
835
301
4638
0.64
13.14
1.2
1.3
44.5
49.0
au/ml
0.09
11
194
32
73
4.39
13.05
1.2
1.1
—
—
—
0
0
1033
12923
0.77
13.02
1.4
1.3
2.5
2.6
g/l
0.70
643
7328
342
5112
0.66
12.93
2.3
2.4
23.4
27.1
au/ml
0.11
11
204
268
1662
1.63
12.72
1.4
1.6
—
—
—
0
0
74
292
2.55
12.63
1.1
1.1
—
—
—
0
0
72
1682
0.42
12.49
1.3
1.2
—
19.8
—
0
21
175
3005
0.57
11.96
1.3
1.6
—
—
—
0
0
283
1806
1.58
11.96
5.8
7.0
104.3
104.8
mmol/l
0.83
253
1628
106
2111
0.50
11.90
1.3
1.2
26.0
40.2
u/ml
—
7
133
49
162
3.04
11.68
1.5
1.1
2.0
2.6
ug/l
0.45
23
120
87
385
2.27
11.58
2.0
1.6
—
—
—
0
0
207
3350
0.61
11.22
1.3
1.7
—
—
—
0
0
98
1960
0.49
11.17
1.3
1.3
2.7
4.8
u/ml
2.11
22
322
211
3374
0.62
10.88
1.0
1.1
—
—
—
0
0
98
1936
0.50
10.78
1.3
1.3
1.7
8.5
u/ml
1.67
15
206
88
1802
0.48
10.77
1.1
1.1
5.6
9.6
u/ml
—
5
162
186
1099
1.71
10.70
1.2
1.4
—
15.8
—
0
26
38
114
3.34
10.64
4.3
1.2
—
—
—
0
0
62
1431
0.43
10.51
1.8
1.8
147.6
195.7
pmol/l
3.48
55
1341
32
87
3.69
10.38
1.1
1.1
—
—
—
0
0
3661
39913
0.86
10.28
2.5
2.4
—
—
—
0
0
91
433
2.11
10.18
1.8
1.2
111.4
88.3
u/l
0.89
84
371
27
66
4.10
10.13
1.0
1.1
18.6
10.1
iu/ml
0.24
14
21
88
415
2.13
10.08
2.0
2.0
2.3
2.7
u/field
0.29
68
279
9
474
0.19
10.02
1.0
1.1
—
0.2
—
0
116
167
979
1.72
9.92
1.2
1.5
111.3
117.6
u/ml
0.32
37
201
138
2391
0.57
9.81
1.5
1.7
—
—
—
0
0
18
32
5.63
9.73
1.0
1.2
—
—
—
0
0
87
417
2.10
9.58
1.9
1.2
48.0
21.1
u/l
2.57
77
350
163
966
1.70
9.33
5.2
14.3
7.3
7.5
mmol/l
0.31
145
789
81
1617
0.50
9.26
1.2
1.2
1.1
6.7
u/ml
—
8
133
19
725
0.26
9.14
1.0
1.0
773.6
708.5
ng/l
0.26
11
471
7559
72967
1.18
9.12
40.7
12.6
79.4
76.0
ml/min/173m2
40.14
7043
58961
20
728
0.27
8.88
1.0
1.0
37.0
44.5
ng/l
0.33
12
483
20
721
0.28
8.73
1.1
1.0
460.5
341.7
ng/l
0.34
14
487
195
2994
0.64
8.46
1.1
1.2
2.3
0.8
u/ml
0.34
15
277
364
2629
1.40
8.43
4.0
1.6
1.4
2.4
ratio
1.40
25
210
84
419
2.01
8.37
1.7
1.5
—
—
—
0
0
32
885
0.36
8.36
1.1
1.1
0.2
1.1
u/ml
—
10
349
27
78
3.47
8.07
1.0
2.3
—
—
—
0
0
76
1469
0.51
7.93
1.2
1.2
39.4
44.8
u/ml
0.11
12
161
1962
22054
0.86
7.81
3.0
2.5
2432.9
5591.0
umol/l
2.58
1687
18727
80
404
1.99
7.73
1.0
1.0
—
—
—
0
0
369
2718
1.37
7.63
4.1
1.6
47.7
47.9
mg/l
0.01
300
2192
368
2712
1.37
7.58
4.1
1.6
72.8
37.7
mg/l
0.53
297
2179
293
2084
1.42
7.45
1.2
1.2
—
—
—
0
0
295
2102
1.42
7.43
1.2
1.2
—
—
—
0
0
44
991
0.44
7.15
1.1
1.0
—
—
—
0
0
32
112
2.86
7.03
1.1
1.1
6.2
4.3
pmol/l
—
8
8
3320
30640
1.13
7.03
2.4
2.8
398.8
137.1
ug/l
49.73
3069
27992
78
1436
0.54
7.00
1.4
1.7
—
—
—
0
0
112
652
1.73
6.96
2.2
2.2
3.1
1.9
u/field
1.01
59
247
55
1130
0.48
6.96
1.3
1.6
—
—
—
0
0
34
126
2.70
6.74
2.3
1.4
44.9
41.0
u/l
0.05
34
113
685
8318
0.81
6.47
1.4
1.4
—
—
—
0
0
978
8306
1.20
6.35
2.3
2.4
4.4
8.0
ug/l
10.86
857
7249
25
81
3.09
6.30
1.7
1.5
51.0
55.0
pmol/l
0.06
20
68
146
2226
0.65
6.23
1.6
1.7
—
—
—
0
0
149
2260
0.65
6.21
1.4
1.6
0.1
2.6
iu/ml
0.91
42
494
176
2573
0.68
6.10
1.3
1.4
—
—
—
0
0
155
2307
0.67
5.90
1.5
1.6
13365.5
14015.0
e6/l
0.09
118
1676
26
92
2.83
5.65
1.2
1.6
—
—
—
0
0
36
777
0.46
5.34
1.0
1.1
2.7
3.6
u/ml
—
7
301
50
249
2.01
5.16
1.4
1.3
28.1
29.6
umol/l
0.57
50
238
596
4932
1.22
5.10
2.3
2.3
10.0
10.9
g/l
3.45
522
4497
55
285
1.94
5.08
1.7
2.1
483.5
438.8
e6/l
0.31
45
246
8625
84897
1.19
5.00
55.1
20.1
252.2
243.5
e9/l
21.23
8422
82173
6927
67272
1.11
4.81
34.8
15.1
36.1
39.5
%
131.93
4267
43866
8626
84941
1.18
4.79
55.0
20.1
6.9
6.7
e9/l
9.78
8407
81898
8625
84935
1.18
4.76
55.0
20.1
4.1
4.5
e12/l
307.65
8406
81883
8625
84946
1.18
4.70
55.3
20.2
121.6
136.3
g/l
307.65
8475
83409
5
232
0.22
4.67
1.8
1.6
16.3
8.9
ug/l
—
5
232
500
4105
1.23
4.65
1.2
1.2
139.8
134.6
iu/ml
0.08
110
1534
25
578
0.43
4.51
1.2
1.1
—
36.8
—
0
5
638
7523
0.84
4.48
1.6
1.7
1.6
1.5
%
1.11
515
6388
18
62
2.91
4.16
1.8
1.2
—
—
—
0
0
5650
58460
0.92
4.12
3.4
4.2
23.1
12.4
mm/h
179.95
5069
53705
7
249
0.28
4.12
1.3
1.5
—
—
—
0
0
717
6169
1.18
4.06
3.0
3.9
100.0
95.5
ng/l
0.46
625
5246
105
701
1.50
3.91
1.4
1.6
—
—
—
0
0
101
1496
0.67
3.90
1.3
1.5
—
—
—
0
0
34
165
2.06
3.84
2.0
2.9
—
—
—
0
0
146
2005
0.72
3.70
1.8
1.7
—
—
—
0
0
62
373
1.67
3.61
1.1
1.1
—
—
—
0
0
54
316
1.71
3.49
1.2
1.4
—
—
—
0
0
54
316
1.71
3.49
1.2
1.4
—
—
—
0
0
29
573
0.50
3.48
1.2
1.4
—
—
—
0
0
46
258
1.79
3.45
1.7
2.4
—
—
—
0
0
46
258
1.79
3.45
1.7
2.4
—
—
—
0
0
30
146
2.06
3.40
1.8
2.2
—
—
—
0
0
146
1073
1.37
3.29
1.8
1.3
1.9
3.1
nmol/l
0.28
140
1027
42
729
0.57
3.28
1.3
1.7
48.5
24.4
u/ml
1.79
13
170
8
240
0.33
3.28
1.1
1.1
—
—
—
0
0
15
54
2.78
3.25
1.5
1.4
1.7
0.7
ml/s/173m2
—
7
34
26
518
0.50
3.22
1.5
1.3
3.5
1.0
u/ml
0.35
16
270
149
1108
1.35
3.14
1.6
1.6
—
—
—
0
0
52
312
1.67
3.11
1.2
1.2
—
—
—
0
0
24
472
0.51
2.90
1.5
1.4
17.6
5.8
u/l
0.92
19
393
18
76
2.37
2.88
1.1
1.1
—
—
—
0
0
15
349
0.43
2.88
1.3
1.5
—
—
—
0
0
46
274
1.68
2.85
1.7
2.1
0.2
0.2
e9/l
0.06
41
244
85
1216
0.70
2.83
1.5
1.5
68.8
59.8
%
1.62
55
780
143
1076
1.33
2.82
1.8
1.3
0.6
0.3
nmol/l
0.37
17
81
29
531
0.54
2.80
1.0
1.2
—
—
—
0
0
29
530
0.55
2.78
1.0
1.2
—
—
—
0
0
29
529
0.55
2.76
1.0
1.2
—
—
—
0
0
177
2256
0.78
2.74
1.2
1.5
1.2
1.2
g/l
1.33
161
2128
29
526
0.55
2.72
1.0
1.2
—
—
—
0
0
29
526
0.55
2.72
1.0
1.2
—
—
—
0
0
3028
31769
0.93
2.70
2.1
2.2
76.8
78.6
nmol/l
2.63
2787
27836
6
10
6.00
2.69
1.0
1.0
—
—
—
0
0
7
198
0.35
2.65
1.9
1.6
188.7
119.2
ng/l
—
7
198
239
2928
0.81
2.63
1.4
1.6
136.7
305.7
titre
—
6
142
135
1022
1.33
2.59
1.3
1.4
—
—
—
0
0
36
605
0.59
2.57
1.2
1.1
—
—
—
0
0
14
318
0.44
2.57
1.1
1.4
—
—
—
0
0
349
2950
1.19
2.55
1.2
1.3
—
—
—
0
0
62
410
1.52
2.54
3.1
4.0
—
—
—
0
0
15
62
2.42
2.53
1.2
1.1
—
—
—
0
0
57
373
1.53
2.46
1.3
1.7
—
—
—
0
0
177
2210
0.80
2.35
1.2
1.6
0.3
0.2
g/l
1.61
163
2091
10
35
2.86
2.30
1.0
1.1
—
—
—
0
0
6
13
4.62
2.27
3.5
1.0
—
—
—
0
0
32
186
1.72
2.23
1.0
1.1
—
—
—
0
0
135
1047
1.29
2.23
1.1
1.2
—
—
—
0
0
833
9151
0.90
2.18
1.3
1.4
—
—
—
0
0
31
184
1.69
2.03
1.0
1.1
—
—
—
0
0
15
300
0.50
2.00
1.1
1.4
—
—
—
0
0
15
300
0.50
2.00
1.1
1.4
—
—
—
0
0
15
299
0.50
1.99
1.1
1.4
—
—
—
0
0
15
299
0.50
1.99
1.1
1.4
—
—
—
0
0
70
960
0.73
1.93
1.1
1.1
—
—
—
0
0
84
1110
0.75
1.83
3.3
4.5
330.6
355.2
umol/l
0.98
75
913
124
980
1.27
1.83
1.1
1.2
295.7
288.6
u/ml
0.12
89
630
7
169
0.41
1.77
1.1
1.5
—
—
—
0
0
1834
17391
1.07
1.76
4.8
4.2
1.0
1.0
kg/l
0.01
273
2635
143
1757
0.81
1.73
1.4
1.3
—
—
—
0
0
7
24
2.92
1.72
1.0
1.0
—
—
—
0
0
68
914
0.74
1.69
1.1
1.2
116.8
115.0
%
0.14
58
822
50
706
0.71
1.69
1.1
1.2
90.5
94.2
%
0.50
44
659
14
267
0.52
1.66
1.1
1.1
1800.2
1641.6
miu/ml
0.15
14
267
21
119
1.77
1.65
1.0
1.1
—
—
—
0
0
127
1021
1.25
1.65
2.1
1.3
244.0
266.1
pmol/l
0.28
92
768
11
225
0.49
1.62
1.5
1.7
—
—
—
0
0
69
914
0.75
1.57
1.4
1.3
79271.6
157470.8
e6/l
1.04
52
623
8
33
2.43
1.53
1.0
1.0
—
—
—
0
0
0
43
0.00
1.52
0.0
1.1
—
—
—
0
0
70
918
0.76
1.50
1.2
1.2
8.2
7.7
mmol/l
0.72
55
632
1801
17170
1.06
1.46
1.8
1.8
1274.9
1152.1
nmol/l
5.08
1398
12888
3486
33822
1.05
1.45
11.2
4.0
26.2
2.3
ug/l
16.83
3126
30258
9
38
2.37
1.45
4.8
1.4
—
—
—
0
0
19
316
0.60
1.43
1.6
1.8
14.4
441.0
ug/l
1.20
19
293
42
295
1.43
1.41
1.6
1.7
15.3
5.3
nmol/l
0.98
37
245
7
29
2.41
1.39
1.3
1.0
273.9
253.2
nmol/l
—
7
29
68
878
0.77
1.33
1.5
1.5
16.4
29.5
%
3.93
43
564
29
192
1.51
1.31
1.0
1.1
—
—
—
0
0
23
356
0.65
1.30
1.0
1.0
—
—
—
0
0
279
2466
1.14
1.29
2.8
1.5
0.1
0.0
g/l
0.48
249
2233
46
623
0.74
1.27
1.1
1.2
80.0
162.2
titre
1.62
12
111
30
437
0.69
1.27
1.5
1.5
4.3
3.8
%
—
9
100
27
401
0.67
1.26
1.3
1.4
—
—
—
0
0
35
244
1.44
1.25
1.6
1.3
21.9
27.1
%
—
9
32
46
337
1.37
1.24
3.8
5.5
55.9
77.4
mg/l
1.16
33
234
8
36
2.22
1.24
1.3
1.4
—
—
—
0
0
8
37
2.16
1.21
1.0
1.0
—
—
—
0
0
27
395
0.68
1.19
5.3
4.8
42.6
653.1
u/ml
—
5
66
28
189
1.48
1.18
1.0
1.1
—
—
—
0
0
63
489
1.29
1.17
2.8
2.2
196.8
17.2
umol/l
—
5
46
28
192
1.46
1.11
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
50
380
1.32
1.10
1.1
1.1
—
—
—
0
0
79
974
0.81
1.10
1.2
1.2
2.0
3.8
u/ml
1.33
16
325
29
201
1.44
1.09
1.2
1.3
2.9
3.2
umol/l
0.17
24
188
56
717
0.78
1.08
1.1
1.1
—
—
—
0
0
17
105
1.62
1.05
2.6
2.7
0.7
0.5
u/field
0.37
17
105
17
105
1.62
1.05
1.0
1.2
—
—
—
0
0
18
278
0.65
1.05
11.4
11.9
0.7
0.7
mmol/l
0.12
18
254
308
2786
1.11
1.02
3.2
1.5
1.0
0.5
g/l
1.19
263
2361
95
789
1.21
1.01
1.3
1.3
—
43.2
—
0
5
40
530
0.75
1.01
1.1
1.0
314.1
288.1
mg/l
1.47
31
476
95
792
1.20
0.98
3.7
3.7
—
—
—
0
0
43
326
1.32
0.98
1.6
2.3
55.5
58.2
umol/l
0.19
35
261
75
914
0.82
0.96
1.1
1.1
—
—
—
0
0
11
186
0.59
0.95
1.5
1.6
—
—
—
0
0
79
956
0.82
0.95
1.2
1.2
2.7
4.4
u/ml
2.43
28
431
9
52
1.73
0.92
1.0
1.9
—
—
—
0
0
35
460
0.76
0.87
1.3
1.2
—
—
—
0
0
35
455
0.77
0.81
1.3
1.2
—
—
—
0
0
13
81
1.61
0.81
1.0
1.1
—
—
—
0
0
12
188
0.64
0.79
1.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
5
97
0.52
0.78
1.4
1.8
16.1
18.4
umol/l
—
5
97
18
123
1.46
0.77
1.1
1.2
84.2
131.9
ng/l
—
9
87
22
303
0.73
0.76
1.2
1.2
—
—
—
0
0
253
2312
1.10
0.75
2.9
1.5
0.0
0.0
g/l
0.00
224
2085
359
3332
1.08
0.74
3.2
1.4
3.9
3.9
g/l
0.01
252
2364
336
3112
1.08
0.73
3.3
1.5
3.6
3.0
g/l
10.65
256
2410
16
108
1.48
0.73
1.1
1.1
—
—
—
0
0
359
3336
1.08
0.72
3.2
1.4
—
—
—
0
0
359
3339
1.08
0.71
3.2
1.4
8.2
7.4
g/l
7.67
258
2456
248
2271
1.09
0.71
2.9
1.5
0.0
0.0
g/l
0.00
223
2077
16
109
1.47
0.70
1.0
1.2
—
—
—
0
0
37
465
0.79
0.69
1.0
1.1
0.2
6.5
nmol/l
—
5
99
120
1358
0.88
0.69
4.0
1.2
47.4
26.6
u/l
1.50
108
1165
9
59
1.53
0.68
1.3
1.3
—
—
—
0
0
92
798
1.15
0.67
1.7
2.3
674.1
664.1
ml
0.09
52
546
336
3129
1.08
0.66
3.2
1.5
9.7
10.3
g/l
1.81
275
2605
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
12
78
1.54
0.65
1.0
1.0
—
—
—
0
0
78
903
0.86
0.63
1.0
1.1
10.1
14.3
au/ml
—
6
38
152
1683
0.90
0.62
1.2
1.3
—
—
—
0
0
150
1662
0.90
0.62
1.1
1.1
—
—
—
0
0
29
369
0.79
0.61
1.1
1.2
—
—
—
0
0
2656
27092
0.97
0.60
7.1
3.9
22.2
24.3
%
8.46
1702
13545
0
21
0.00
0.60
0.0
1.0
—
4.0
—
0
16
0
22
0.00
0.59
0.0
1.0
—
12745.6
—
0
9
0
23
0.00
0.58
0.0
1.0
—
1.1
—
0
18
158
1738
0.91
0.58
1.2
1.4
—
—
—
0
0
7
114
0.61
0.57
1.3
1.4
365.4
646.8
mu/l
—
7
106
7
115
0.61
0.57
1.3
1.5
77.9
71.5
%
—
7
107
105
1177
0.89
0.55
1.0
1.1
60.6
10720.2
iu/ml
0.56
31
226
15
107
1.40
0.55
1.0
1.1
—
—
—
0
0
26
328
0.79
0.53
1.2
1.2
38.1
39.5
g/l
0.21
15
163
11
74
1.49
0.53
1.0
1.0
—
—
—
0
0
49
578
0.85
0.53
1.2
1.2
12.1
11.9
mmol/l
0.05
20
166
6
97
0.62
0.52
2.3
2.1
—
—
—
0
0
6
97
0.62
0.52
1.3
1.6
39.7
46.1
umol/l
—
6
97
6
100
0.60
0.51
2.3
2.0
—
—
—
0
0
16
214
0.75
0.51
1.1
1.2
—
—
—
0
0
36
298
1.21
0.48
1.1
1.1
76.0
394.7
ng/l
—
8
75
21
266
0.79
0.46
1.3
1.2
—
—
—
0
0
21
164
1.28
0.46
1.4
1.2
89.7
65.0
mu/l
0.23
15
116
52
601
0.86
0.46
1.3
1.4
0.9
1.3
promille
1.03
37
453
2010
20496
0.98
0.46
1.6
1.5
18.5
20.3
nmol/l
5.91
1822
17309
5
83
0.60
0.45
1.0
1.3
4.6
13.4
pmol/l
—
5
72
23
183
1.26
0.44
1.0
1.1
87.1
86.4
%
—
10
90
13
175
0.74
0.44
1.0
1.1
—
—
—
0
0
180
1934
0.93
0.43
2.6
3.0
0.8
0.8
nmol/l
0.11
131
1498
14
104
1.35
0.43
1.0
1.1
—
—
—
0
0
5
31
1.61
0.43
1.2
1.1
8.8
8.2
mmol/l
—
5
31
303
3196
0.95
0.42
1.5
1.9
37.3
38.6
u/l
0.54
271
2752
8
59
1.36
0.41
1.3
1.1
17.0
13.4
u/l
—
8
59
0
17
0.00
0.40
0.0
1.2
—
3.4
—
0
17
60
530
1.13
0.40
1.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
13
97
1.34
0.39
1.5
1.5
—
—
—
0
0
0
19
0.00
0.39
0.0
4.3
—
—
—
0
0
11
80
1.38
0.38
1.0
1.2
—
—
—
0
0
34
289
1.18
0.37
1.6
2.0
70.6
52.0
ug/l
1.01
34
281
41
359
1.14
0.33
1.0
1.1
—
—
—
0
0
228
2400
0.95
0.32
2.2
2.3
123.9
118.1
ug/min
0.06
121
1407
24
201
1.19
0.32
1.6
2.3
1.0
0.9
ug/l
0.21
24
187
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
273
2611
1.05
0.30
2.8
1.5
35.6
37.6
g/l
5.68
235
2203
8
109
0.73
0.29
2.9
1.5
—
—
—
0
0
42
373
1.13
0.28
1.3
1.5
18.1
8.9
umol/l
0.81
32
261
16
130
1.23
0.28
1.1
1.2
80.8
78.4
%
—
5
49
31
355
0.87
0.28
1.0
1.1
1.1
1.1
ratio
—
10
122
1860
18857
0.98
0.27
4.0
2.8
1.6
0.7
ug/l
20.13
1442
13247
21
177
1.19
0.27
1.0
1.1
68.6
87.6
%
—
8
91
40
357
1.12
0.26
1.1
1.2
—
—
—
0
0
11
86
1.28
0.26
1.2
1.0
—
—
—
0
0
55
603
0.91
0.25
1.1
1.1
—
—
—
0
0
137
1296
1.06
0.25
1.2
1.2
—
—
—
0
0
193
1846
1.05
0.24
1.4
1.3
690.6
551.7
mg/l
1.62
187
1746
36
322
1.12
0.23
1.4
2.0
83.1
125.6
umol/l
0.79
18
174
169
1613
1.05
0.23
1.3
1.2
3.7
3.9
mmol/l
1.79
157
1516
20
171
1.17
0.23
1.0
1.1
—
—
—
0
0
21
181
1.16
0.22
2.2
2.6
6.7
8.1
mmol/l
0.97
14
116
46
419
1.10
0.22
2.1
2.4
—
—
—
0
0
189
1812
1.04
0.22
3.7
3.5
35.7
26.7
mg/l
2.08
124
1174
30
336
0.89
0.21
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
163
1702
0.96
0.21
1.7
1.5
0.9
0.8
nmol/l
0.70
141
1394
0
13
0.00
0.21
0.0
5.8
—
0.3
—
0
13
34
306
1.11
0.20
1.4
1.3
59.7
21.8
umol/l
5.26
34
287
10
80
1.25
0.20
1.2
1.1
—
—
—
0
0
123
1171
1.05
0.20
1.1
1.2
168.8
218.0
miu/ml
0.89
37
474
35
386
0.91
0.20
1.1
1.3
—
—
—
0
0
6
52
1.15
0.19
1.5
1.2
—
—
—
0
0
6
53
1.13
0.18
1.0
2.0
—
—
—
0
0
18
206
0.87
0.18
1.4
1.3
—
—
—
0
0
168
1618
1.04
0.17
1.4
1.4
30.7
22.1
e6/l
0.19
128
1274
168
1621
1.04
0.16
1.5
1.4
740.0
1615.0
e6/l
1.10
137
1351
16
183
0.87
0.16
1.0
1.2
—
—
—
0
0
21
187
1.12
0.15
1.0
1.4
—
—
—
0
0
9
78
1.15
0.15
1.1
1.1
—
—
—
0
0
51
479
1.06
0.14
1.5
1.3
1.1
1.2
nmol/l
0.21
43
363
12
139
0.86
0.14
1.3
1.4
7.3
9.3
mmol/l
—
5
75
69
724
0.95
0.13
1.1
1.1
—
22.7
—
0
9
33
306
1.08
0.12
1.2
1.1
—
—
—
0
0
45
423
1.06
0.12
1.1
1.1
360.9
288.7
mg/l
0.94
38
384
1895
18816
1.01
0.12
1.8
1.7
10864329.8
34471909.2
pmol/l
2.04
1528
15288
18
162
1.11
0.11
1.1
1.2
—
—
—
0
0
35
374
0.94
0.11
1.1
1.2
—
—
—
0
0
17
153
1.11
0.11
1.2
1.8
—
—
—
0
0
24
260
0.92
0.11
1.2
1.1
—
—
—
0
0
33
352
0.94
0.10
1.8
2.1
1058.5
810.8
u/ml
0.85
33
346
38
358
1.06
0.10
1.5
1.2
68.9
51.3
%
—
7
32
1104
11121
0.99
0.09
15.3
7.1
—
—
—
0
0
15
136
1.10
0.08
1.1
1.4
57.0
46.9
%
—
8
55
48
459
1.05
0.08
2.1
2.1
25.1
166.7
ug/min
—
8
121
32
302
1.06
0.08
1.1
1.1
144.5
202.3
iu/ml
1.04
32
297
112
1091
1.03
0.08
1.9
2.2
42.7
25.9
mg/l
1.39
30
288
30
317
0.95
0.07
1.1
1.1
1.0
1.1
u/l
0.26
17
144
39
408
0.96
0.07
1.0
1.1
—
—
—
0
0
20
212
0.94
0.05
1.1
1.7
243.7
187.6
%
0.95
20
198
201
1987
1.01
0.04
1.5
1.9
9.8
11.3
mg/l
1.96
185
1839
16
170
0.94
0.04
1.4
1.1
—
—
—
0
0
46
452
1.02
0.01
1.1
1.1
52.5
40.7
mg/l
0.91
39
393
77
776
0.99
0.00
1.3
1.3
1.4
1.4
nmol/l
0.01
71
700
19
187
1.02
0.00
1.0
1.1
—
—
—
0
0
16
165
0.97
0.00
1.1
1.1
0.6
0.7
umol/24h
—
7
70
11
112
0.98
0.00
10.5
12.2
5.1
5.1
mmol/l
0.02
11
112
19
185
1.03
0.00
1.3
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
0.00
1.1
1.2
1.5
1.8
umol/24h
—
7
71
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
5
58
0.86
0.00
1.0
1.1
—
13.6
—
0
11
8
88
0.91
0.00
1.7
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SECONDARY_NAS_EXALLC – Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).